8-6-3-2　ⓔ文献

  1. Meine TJ, Al–Khatib SM, et al: Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy. Am Heart J, 2005; 149: 670–674.

  2. Harris A, Davies M, et al: Aetiology of chronic heart block. A clinico–pathological correlation in 65 cases. Br Heart J, 1969; 31: 206–218.

  3. Dubrey SW, Falk RH: Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis, 2010; 52: 336–346.

  4. Villain E, Coastedoat–Chalumeau N, et al: Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status. J Am Coll Cardiol, 2006; 48: 1682–1687.

  5. Zeltser D, Justo D, et al: Drug–induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol, 2004 ; 44: 105–108.

  6. Osmonov D, Erdinler I, et al: Management of patients with drug–induced atrioventricular block. Pacing Clin Electrophysiol, 2012; 35: 804–810.

  7. 大江　透：房室ブロック．不整脈―ベッドサイド診断から非薬物治療まで，医学書院，2007；221–232．

  8. 2010年度合同研究班報告：循環器病の診断と治療に関するガイドライン．臨床心臓電気生理検査に関するガイドライン (2011年改訂版), 2011; 8–10. http://www.j-circ.or.jp/guideline/pdf/JCS2011_ogawas_h.pdf

  9. Narula OS: Atrioventricular Block. Cardiac Arrhythmias: Electrophysiology, Diagnosis and Management (Narula OS ed), Williams & Wilkins, 1979; 85–113.

  10. 日本循環器学会/日本不整脈心電学会合同ガイドライン：不整脈の非薬物治療ガイドライン (2018年改訂版), 2018; 19–20. http://www.j-circ.or.jp/guideline/pdf/JCS2018_kurita_nogami.pdf